SEARCH

SEARCH BY CITATION

References

  • 1
    Dinarello C, Arend W, Sims J, Smith D, Blumberg H, O'Neill L, Goldbach-Mansky R, Pizarro T, Hoffman H, Bufler P, Nold M, Ghezzi P, Mantovani A, Garlanda C, Boraschi D, Rubartelli A, Netea M, van der Meer J, Joosten L, Mandrup-Poulsen T, Donath M, Lewis E, Pfeilschifter J, Martin M, Kracht M, Muehl H, Novick D, Lukic M, Conti B, Solinger A, Kelk P, van de Veerdonk F, Gabel C (2010) IL-1 family nomenclature. Nat Immunol 11:973.
  • 2
    Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519550.
  • 3
    Arend WP, Palmer G, Gabay C (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223:2038.
  • 4
    O'Neill LA (2008) The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 226:1018.
  • 5
    Heguy A, Baldari CT, Macchia G, Telford JL, Melli M (1992) Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the Drosophila toll protein are essential for IL-1R signal transduction. J Biol Chem 267:26052609.
  • 6
    Fallon PG, Allen RL, Rich T (2001) Primitive Toll signalling: bugs, flies, worms and man. Trends Immunol 22:6366.
  • 7
    Botos I, Segal DM, Davies DR (2011) The structural biology of Toll-like receptors. Structure 19:447459.
  • 8
    Bowie A, O'Neill LA (2000) The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 67:508514.
  • 9
    Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:20952147.
  • 10
    Dinarello CA (2013) Overview of the interleukin-1 family of ligands and receptors. Semin Immunol 25:389393.
  • 11
    Sims JE, Smith DE (2010) The IL-1 family: regulators of immunity. Nat Rev Immunol 10:89102.
  • 12
    Mandinova A, Soldi R, Graziani I, Bagala C, Bellum S, Landriscina M, Tarantini F, Prudovsky I, Maciag T (2003) S100A13 mediates the copper-dependent stress-induced release of IL-1alpha from both human U937 and murine NIH 3T3 cells. J Cell Sci 116:26872696.
  • 13
    Prudovsky I, Mandinova A, Soldi R, Bagala C, Graziani I, Landriscina M, Tarantini F, Duarte M, Bellum S, Doherty H, Maciag T (2003) The non-classical export routes: FGF1 and IL-1alpha point the way. J Cell Sci 116:48714881.
  • 14
    Hurgin V, Novick D, Werman A, Dinarello CA, Rubinstein M (2007) Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha. Proc Natl Acad Sci USA 104:50445049.
  • 15
    Andrei C, Margiocco P, Poggi A, Lotti LV, Torrisi MR, Rubartelli A (2004) Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: implications for inflammatory processes. Proc Natl Acad Sci USA 101:97459750.
  • 16
    Andrei C, Dazzi C, Lotti L, Torrisi MR, Chimini G, Rubartelli A (1999) The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol Biol Cell 10:14631475.
  • 17
    Qu Y, Franchi L, Nunez G, Dubyak GR (2007) Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 179:19131925.
  • 18
    Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, McMahan CJ, Grubin CE, Wignall JM, Jackson JL, Call SM, Friend D, Alpert AR, Gillis S, Urdal DL, Dower SK (1988) cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241:585589.
  • 19
    Korherr C, Hofmeister R, Wesche H, Falk W (1997) A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur J Immunol 27:262267.
  • 20
    Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G (1995) Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 270:1375713765.
  • 21
    Hou J, Townson SA, Kovalchin JT, Masci A, Kiner O, Shu Y, King BM, Schirmer E, Golden K, Thomas C, Garcia KC, Zarbis-Papastoitsis G, Furfine ES, Barnes TM (2013) Design of a superior cytokine antagonist for topical ophthalmic use. Proc Natl Acad Sci USA 110:39133918.
  • 22
    Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12:5371.
  • 23
    Boraschi D, Dinarello CA (2006) IL-18 in autoimmunity: review. Eur Cytokine Netw 17:224252.
  • 24
    Boraschi D, Tagliabue A (2006) The interleukin-1 receptor family. Vitam Horm 74:229254.
  • 25
    Dinarello CA, Fantuzzi G (2003) Interleukin-18 and host defense against infection. J Infect Dis 187:S370S384.
  • 26
    Bazan JF, Timans JC, Kastelein RA (1996) A newly defined interleukin-1? Nature 379:596.
  • 27
    Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M (1995) Cloning of a new cytokine that induces IFN gamma production by T cells. Nature 378:8891.
  • 28
    Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F, O'Garra A (1997) IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7:571581.
  • 29
    Okamoto M, Kato S, Oizumi K, Kinoshita M, Inoue Y, Hoshino K, Akira S, McKenzie AN, Young HA, Hoshino T (2002) Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia. Blood 99:12891298.
  • 30
    Nakahira M, Ahn HJ, Park WR, Gao P, Tomura M, Park CS, Hamaoka T, Ohta T, Kurimoto M, Fujiwara H (2002) Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol 168:11461153.
  • 31
    Gu Y (1997) Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275:206209.
  • 32
    Debets R, Timans JC, Churakowa T, Zurawski S, de Waal Malefyt R, Moore KW, Abrams JS, O'Garra A, Bazan JF, Kastelein RA (2000) IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18. J Immunol 165:49504956.
  • 33
    Wu C, Sakorafas P, Miller R, McCarthy D, Scesney S, Dixon R, Ghayur T (2003) IL-18 receptor beta-induced changes in the presentation of IL-18 binding sites affect ligand binding and signal transduction. J Immunol 170:55715577.
  • 34
    Kim S, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M, Dinarello CA (2000) Structural requirements of six naturally occuring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 97:11901195.
  • 35
    Novick D, Kim S, Fantuzzi G, Reznokov LL, Dinarello CA, Rubinstein M (1999) Interleukin-18 binding protein: A novel modulator of the Th1 cutokine response. Immunity 10:127136.
  • 36
    Novick D, Schwartsburd B, Pinkus R, Suissa D, Belzer I, Sthoeger Z, Keane WF, Chvatchko Y, Kim SH, Fantuzzi G, Dinarello GA, Rubinstein M (2001) A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 14:334342.
  • 37
    Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S, Kirkpatrick RB, Scott GF, Lee JC, Lynch FJ, Gao W, Gambotto A, Lotze MT (2002) Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18:6171.
  • 38
    Pan G, Risser P, Mao W, Baldwin DT, Zhong AW, Filvaroff E, Yansura D, Lewis L, Eigenbrot C, Henzel WJ, Vandlen R (2001) IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine 13:17.
  • 39
    Lefrancais E, Cayrol C (2012) Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members. Eur Cytokine Netw 23:120127.
  • 40
    Lefrancais E, Roga S, Gautier V, Gonzalez-de-Peredo A, Monsarrat B, Girard JP, Cayrol C (2012) IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci USA 109:16731678.
  • 41
    Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479490.
  • 42
    Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, Martin MU (2007) IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA 104:1866018665.
  • 43
    Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA (2007) IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 179:25512555.
  • 44
    Kato Z, Jee J, Shikano H, Mishima M, Ohki I, Ohnishi H, Li A, Hashimoto K, Matsukuma E, Omoya K, Yamamoto Y, Yoneda T, Hara T, Kondo N, Shirakawa M (2003) The structure and binding mode of interleukin-18. Nat Struct Biol 10:966971.
  • 45
    Liu X, Hammel M, He Y, Tainer JA, Jeng US, Zhang L, Wang S, Wang X (2013) Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci USA 110:1491814923.
  • 46
    Vigers GPA, Andersen LA, Caffes P, Brandhuber BJ (1997) Crystal structure of the type-1 interleukin-1 receptor comlexed with interleukin-1beta. Nature 386:190194.
  • 47
    MacDonald HR, Wingfield P, Schmeissner U, Shaw A, Clore GM, Gronenborn AM (1986) Point mutations of human interleukin-1 with decreased receptor binding affinity. FEBS Lett 209:295298.
  • 48
    Evans RJ, Bray J, Childs JD, Vigers GP, Brandhuber BJ, Skalicky JJ, Thompson RC, Eisenberg SP (1995) Mapping receptor binding sites in interleukin (IL)−1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta. J Biol Chem 270:1147711483.
  • 49
    Lingel A, Weiss TM, Neibuhr M, Pan B, Appleton BA, Weisman C, Bazan JF, Fairbrother WJ (2009) Structure of IL-33 and its interaction with the ST2 and IL-1Racp Receptors—insight into heterotrimeric IL-1 Signaling Cascade. Structure 17:13981410.
  • 50
    Labriola-Tompkins E, Chandran C, Kaffka KL, Biondi D, Graves BJ, Hatada M, Madison VS, Karas J, Kilian PL, Ju G (1991) Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor. Proc Natl Acad Sci USA 88:1118211186.
  • 51
    Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774797.
  • 52
    Wang D, Zhang S, Li L, Liu X, Mei K, Wang X (2010) Structural insights into the assembly and activation of IL-1beta with its receptors. Nat Immunol 11:905911.
  • 53
    Casadio R, Frigimelica E, Bossu P, Neumann D, Martin MU, Tagliabue A, Boraschi D (2001) Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex. FEBS Lett 499:6568.
  • 54
    Thomas C, Bazan JF, Garcia KC (2012) Structure of the activating IL-1 receptor signaling complex. Nat Struct Mol Biol 19:455457.
  • 55
    Greenfeder SA, Varnell T, Powers G, Lombard-Gillooly K, Shuster D, McIntyre KW, Ryan DE, Levin W, Madison V, Ju G (1995) Insertion of a structural domain of interleukin (IL)−1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity. J Biol Chem 270:2246022466.
  • 56
    Kim SH, Azam T, Novick D, Yoon DY, Reznikov LL, Bufler P, Rubinstein M, Dinarello CA (2002) Identification of amino acid residues critical for biological activity in human interleukin-18. J Biol Chem 277:1099811003.
  • 57
    Meng X, Leman M, Xiang X (2007) Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit. Virology 358:211220.
  • 58
    Argiriadi MA, Xiang T, Wu C, Ghayur T, Borhani DW (2009) Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18. J Biol Chem 284:2447824489.
  • 59
    Schreuder H, Tardif C, Trump-Kallmeyer S, Soffienti A, Sarubbi E, Akeson A, Bowlin T, Yanofsky S, Barret RW (1997) A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386:194200.
  • 60
    Parker S, Nuara A, Buller RM, Schultz DA (2007) Human monkeypox: an emerging zoonotic disease. Future Microbiol 2:1734.
  • 61
    Born TL, Morrison LA, Esteban DJ, VandenBos T, Thebeau LG, Chen N, Spriggs MK, Sims JE, Buller RML (2000) A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J Immunol 164:32463254.
  • 62
    Xiang Y, Moss B (1999) IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc Natl Acad Sci USA 96:1153711542.
  • 63
    Calderara S, Xiang Y, Moss B (2001) Orthopoxvirus IL-18 binding proteins: affinities and antagonist activities. Virology 279:2226.
  • 64
    Reading PC, Smith GL (2003) Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol 77:99609968.
  • 65
    Krumm B, Meng X, Wang Z, Xiang Y, Deng J (2012) A unique bivalent binding and inhibition mechanism by the yatapoxvirus interleukin 18 binding protein. PLoS Pathog 8:e1002876.
  • 66
    Krumm B, Meng X, Li Y, Xiang Y, Deng J (2008) Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein. Proc Natl Acad Sci USA 105:2071120715.
  • 67
    Esteban DJ, Buller RM (2004) Identification of residues in an orthopoxvirus interleukin-18 binding protein involved in ligand binding and species specificity. Virology 323:197207.
  • 68
    Xiang Y, Moss B (2001) Determination of the functional epitopes of human interleukin-18 binding protein by site-directed mutagenesis. J Biol Chem 276:1738017386.
  • 69
    Xiang Y, Moss B (2001) Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins. J Virol 75:99479954.
  • 70
    Reuter BK, Asfaha S, Buret A, Sharkey KA, Wallace JL (1996) Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 98:2076.
  • 71
    Dinarello CA (2003) Anti-cytokine therapeutics and infections. Vaccine 21:S24S34.
  • 72
    Dinarello CA, Novick D, Kim S, Kaplanski G (2013) Interleukin-18 and IL-18 binding orotein. Front Immunol 4:289.
  • 73
    Kimura T, Kato Z, Ohnishi H, Tochio H, Shirakawa M, Kondo N (2008) Expression, purification and structural analysis of human IL-18 binding protein: a potent therapeutic molecule for allergy. Allergology Intl 57:367376.
  • 74
    Plitz TS-MP, Satho M, Herren S, Waltzinger C, de Carvalho Bittencourt M, Kosco-Vilbois MH, Chvatchko Y (2003) IL-18 binding protein protects against contact hypersensitivity. J Immunol 3:11641171.
  • 75
    Boraschi D, Bossu P, Macchia G, Ruggiero P, Tagliabue A (1996) Structure-function relationship in the IL-1 family. Front Biosci 1:d270308.
  • 76
    Ju G, Labriola-Tompkins E, Campen CA, Benjamin WR, Karas J, Plocinski J, Biondi D, Kaffka KL, Kilian PL, Eisenberg SP, et al. (1991) Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis. Proc Natl Acad Sci USA 88:26582662.